drugset / Trial / NCT04641104

The Thiamine Administration After Cardiac Surgery Trial

NCT04641104 ↗

Phase 4 Completed 200 enrolled Sarah Saxena CHU de Charleroi · collab
RandomizedParallel-groupTriple-blindTreatment

Summary

Thiamine (Vitamin B1) is essential for cell function and as a co-factor of the enzyme Pyruvate Dehydrogenase to initiate the Krebs cycle and thus the aerobic metabolism of glucose. We hypothesize that thiamine supplementation improves the clearance of lactate in the first 24 hours after cardiac surgery with extracorporeal circulation in patients with high lactate concentration.

Timeline

Start
2020-11-20
Primary completion
2022-10-03
Completion
2022-10-03

Outcome

Missed primary endpoint

paper There was no difference in the primary outcome of lactate levels at 24 hours after study start PMID 26771781 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Thiamine Other / unclassified 500 mg —